Sigma's plans for Wyeth generic put on hold in Australia
This article was originally published in Scrip
Executive Summary
An injunction by the Australian Federal Court has posed a stumbling block in Sigma Pharmaceuticals' plans to sell a generic version of Wyeth's antidepressant Efexor-XR (venlafaxine hydrochloride) in the country.